Literature DB >> 17578795

Surgical treatment of secondary hyperparathyroidism due to chronic kidney disease.

Yoshihiro Tominaga1.   

Abstract

It is a great honour for me to have this opportunity to present a review about surgical treatment of secondary hyperparathyroidism (2HPT) due to chronic kidney disease (CKD). Uppsala is a historical place concerning the parathyroid gland, because it was here that Ivar Sandström in 1877 initially discovered the small organs, Glandulae Parathyroideae, existing around the thyroid gland in human beings. This finding led to intensive studies of the parathyroid glands, focusing on their histopathology, pathophysiology, clinical diagnosis, and medical and surgical treatment (1) and investigations are still continuing in Uppsala today. I had the privilege to stay in Uppsala during 1989 to study the surgery and pathology of parathyroid glands and it was a pleasure to share clinical and basic research about these small and charming organs with my colleagues in Uppsala.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17578795     DOI: 10.3109/2000-1967-047

Source DB:  PubMed          Journal:  Ups J Med Sci        ISSN: 0300-9734            Impact factor:   2.384


  9 in total

1.  Removal of autografted parathyroid tissue for recurrent renal hyperparathyroidism in hemodialysis patients.

Authors:  Yoshihiro Tominaga; Susumu Matsuoka; Nobuaki Uno; Toyonori Tsuzuki; Takahisa Hiramitsu; Norihiko Goto; Takaharu Nagasaka; Yoshihiko Watarai; Kazuharu Uchida
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

Review 2.  Surgical management of secondary hyperparathyroidism in chronic kidney disease--a consensus report of the European Society of Endocrine Surgeons.

Authors:  Kerstin Lorenz; Detlef K Bartsch; Juan J Sancho; Sebastien Guigard; Frederic Triponez
Journal:  Langenbecks Arch Surg       Date:  2015-10-02       Impact factor: 3.445

3.  Total parathyroidectomy without autotransplantation in the surgical treatment of secondary hyperparathyroidism of chronic kidney disease.

Authors:  G Conzo; A F Perna; A A Sinisi; A Palazzo; F Stanzione; C Della Pietra; A Livrea
Journal:  J Endocrinol Invest       Date:  2011-03-22       Impact factor: 4.256

4.  Preoperative localization of parathyroid lesion: diagnostic usefulness of color doppler ultrasonography.

Authors:  Afshin Mohammadi; Farzad Moloudi; Mohammad Ghasemi-Rad
Journal:  Int J Clin Exp Med       Date:  2012-01-15

5.  PTH Spikes During Surgical Treatment for Secondary and Tertiary Hyperparathyroidism: A Prospective Observational Study.

Authors:  Andre Albuquerque Silveira; Marilia D'Elboux Guimaraes Brescia; Climerio Pereira do Nascimento; Felipe Ferraz Magnabosco; Sergio Samir Arap; Fabio Luiz de Menezes Montenegro
Journal:  World J Surg       Date:  2022-03-09       Impact factor: 3.282

6.  Severe secondary hyperparathyroidism and panoramic radiography parameters.

Authors:  João César Guimarães Henriques; Julio Cezar de Melo Castilho; Reinhilde Jacobs; José Benedito Oliveira Amorim; Rafaela Rangel Rosa; Caio Vinícius Bardi Matai
Journal:  Clin Oral Investig       Date:  2013-07-12       Impact factor: 3.573

7.  Current status of parathyroidectomy for secondary hyperparathyroidism in Japan.

Authors:  Yoshihiro Tominaga
Journal:  NDT Plus       Date:  2008-08

8.  The Significance of Ultrasound in Determining Whether SHPT Patients Are Sensitive to Calcitriol Treatment.

Authors:  Xing-xin Liang; Fan Li; Feng Gao; Chun-xiao Li; Xiao-hui Qiao; Jia-jie Zhang; Lian-fang Du
Journal:  Biomed Res Int       Date:  2016-02-29       Impact factor: 3.411

9.  Predictors of early postoperative hypocalcemia after total parathyroidectomy in renal hyperparathyroidism.

Authors:  Poh Guan Tan; Imi Sairi Ab Hadi; Zalina Zahari; Maya Mazuwin Yahya; Wan Zainira Wan Zain; Michael Pak-Kai Wong; Rosnelifaizur Ramely; Mohd Nizam Md Hashim; Syed Hassan Syed Abd Aziz; Zaidi Zakaria; Andee Dzulkarnaen Zakaria
Journal:  Ann Surg Treat Res       Date:  2019-12-30       Impact factor: 1.859

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.